Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Medical Oncology
- Vol. 13
Abstract
Introduction: Studies of the impact of hepatitis C virus (HCV), hepatitis B virus (HBV) and HIV mono and co-infections on the risk of cancer, particularly extra-hepatic cancer, have been limited and inconsistent in their findings. Methods: In the British Columbia Hepatitis Testers Cohort, we assessed the risk of colorectal, liver, and pancreatic cancers in association with HCV, HBV and HIV infection status. Using Fine and Gray adjusted proportional subdistribution hazards models, we assessed the impact of infection status on each cancer, accounting for competing mortality risk. Cancer occurrence was ascertained from the BC Cancer Registry. Results: Among 658,697 individuals tested for the occurrence of all three infections, 1407 colorectal, 1294 liver, and 489 pancreatic cancers were identified. Compared to uninfected individuals, the risk of colorectal cancer was significantly elevated among those with HCV (Hazard ration [HR] 2.99; 95% confidence interval [CI] 2.55–3.51), HBV (HR 2.47; 95% CI 1.85–3.28), and HIV mono-infection (HR 2.30; 95% CI 1.47–3.59), and HCV/HIV co-infection. The risk of liver cancer was significantly elevated among HCV and HBV mono-infected and all co-infected individuals. The risk of pancreatic cancer was significantly elevated among individuals with HCV (HR 2.79; 95% CI 2.01–3.70) and HIV mono-infection (HR 2.82; 95% CI 1.39–5.71), and HCV/HBV co-infection. Discussion/Conclusion: Compared to uninfected individuals, the risk of colorectal, pancreatic and liver cancers was elevated among those with HCV, HBV and/or HIV infection. These findings highlight the need for targeted cancer prevention and diligent clinical monitoring for hepatic and extrahepatic cancers in infected populations.Keywords
Funding Information
- Canadian Institutes of Health Research (NHC-348216 and PHE-337680 and PJT-156066)
- Canadian Network on Hepatitis C
- Michael Smith Health Research BC
This publication has 55 references indexed in Scilit:
- Use of name recognition software, census data and multiple imputation to predict missing data on ethnicity: application to cancer registry recordsBMC Medical Informatics and Decision Making, 2012
- Pancreatic cancer: Overview of descriptive epidemiologyMolecular Carcinogenesis, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysisInternational Journal of Cancer, 2010
- Hepatitis C virus infection and risk of cancer: a population-based cohort studyClinical Epidemiology, 2010
- On changes in cancer mortality among HIV-infected patients: is there an excess risk of death from pancreatic cancer?Clinical Infectious Diseases, 2009
- Association Between Hepatitis B Virus and Pancreatic CancerJournal of Clinical Oncology, 2008
- Cancer incidence in people with hepatitis B or C infection: A large community-based linkage studyJournal of Hepatology, 2006
- Viral hepatitis and liver cancer: the case of hepatitis COncogene, 2006
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999